牛叉诊股

[{"date":"2026.08.07","stock":"-0.84","trade":"2.10","ind":"1.42"},{"date":"2026.08.06","stock":"-0.74","trade":"0.32","ind":"-0.24"},{"date":"2026.08.05","stock":"-0.64","trade":"-0.59","ind":"1.86"},{"date":"2026.08.04","stock":"-1.44","trade":"0.61","ind":"3.25"},{"date":"2026.08.03","stock":"1.43","trade":"0.76","ind":"-0.96"},{"date":"2026.07.31","stock":"-1.12","trade":"1.71","ind":"2.21"},{"date":"2026.07.30","stock":"2.68","trade":"-0.93","ind":"-2.73"},{"date":"2026.07.29","stock":"3.46","trade":"0.54","ind":"1.10"},{"date":"2026.07.28","stock":"0.39","trade":"-0.02","ind":"-4.52"},{"date":"2026.07.27","stock":"1.81","trade":"3.54","ind":"2.72"},{"date":"2026.07.24","stock":"-0.78","trade":"-3.55","ind":"-2.47"},{"date":"2026.07.23","stock":"-0.31","trade":"0.55","ind":"0.44"},{"date":"2026.07.22","stock":"0.76","trade":"0.01","ind":"-1.42"},{"date":"2026.07.21","stock":"0.77","trade":"-1.38","ind":"4.81"},{"date":"2026.07.20","stock":"1.06","trade":"0.06","ind":"-0.71"},{"date":"2026.07.17","stock":"-2.47","trade":"-4.74","ind":"-5.40"},{"date":"2026.07.16","stock":"2.70","trade":"1.47","ind":"-1.97"},{"date":"2026.07.15","stock":"2.00","trade":"2.87","ind":"-0.97"},{"date":"2026.07.14","stock":"0.70","trade":"1.54","ind":"2.77"},{"date":"2026.07.13","stock":"4.15","trade":"2.88","ind":"-3.48"},{"date":"2026.07.10","stock":"-0.02","trade":"1.37","ind":"-2.29"}]

东阿阿胶,深证成指,中药指数

压力支撑

该股压力位为53.34元，支撑位为52.85元。

[{"text":"\u538b\u529b\u4f4d","value":"53.34","date":1786032000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"52.85","date":1786032000,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.8资金面打败了46%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：08月07日 20:30

机构今日流向(万元)	1746.42	机构5日流向(万元)	-2339.63
机构10日流向(万元)	-590.76	机构20日流向(万元)	-1174.38

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量减少29987.02万股，其中基金净增仓5家，主力净减仓440家，暂未发现中长期投资价值。

截止2026-06-30，共31家主力机构（基金31家），持仓量总计2293.39万股，占流通A股3.59%
其中，基金持仓与2025-12-31相比：
增仓：9家，增持 265.13万股
减仓：4家，减持 39.46万股
新出现在主力名单中：18家，持有1343.01万股
从主力名单中消失：458家，原持有31555.7万股

消息面诊股

诊断结果：5.5消息面打败了15%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向	公司购买资产	2026-05-27
一般消息	股东大会	临时股东大会	2026-05-19
一般消息	高管变动	工作变动原因	2026-03-25
利好	分红转增	10派14.354904元(含税)	2026-03-20
一般消息	高管变动	由于个人原因	2025-12-22
一般消息	重大事项	关联交易	2025-11-29
一般消息	高管变动	取消监事	2025-11-28
一般消息	高管变动	由于工作变动原因	2025-11-13
一般消息	重大事项	关联交易	2025-11-13
一般消息	重大事项	关联交易	2025-10-29
利好	分红转增	10派12.700919元(含税)	2025-08-22

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：7.7行业面打败了75%的股票中药行业最新资金流向

近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，跑赢大盘。

[{"date":"2026.08.07","price":"1.42","value":"2.10"},{"date":"2026.08.06","price":"-0.24","value":"0.32"},{"date":"2026.08.05","price":"1.86","value":"-0.59"},{"date":"2026.08.04","price":"3.25","value":"0.61"},{"date":"2026.08.03","price":"-0.96","value":"0.76"},{"date":"2026.07.31","price":"2.21","value":"1.71"},{"date":"2026.07.30","price":"-2.73","value":"-0.93"},{"date":"2026.07.29","price":"1.10","value":"0.54"},{"date":"2026.07.28","price":"-4.52","value":"-0.02"},{"date":"2026.07.27","price":"2.72","value":"3.54"},{"date":"2026.07.24","price":"-2.47","value":"-3.55"},{"date":"2026.07.23","price":"0.44","value":"0.55"},{"date":"2026.07.22","price":"-1.42","value":"0.01"},{"date":"2026.07.21","price":"4.81","value":"-1.38"},{"date":"2026.07.20","price":"-0.71","value":"0.06"},{"date":"2026.07.17","price":"-5.40","value":"-4.74"},{"date":"2026.07.16","price":"-1.97","value":"1.47"},{"date":"2026.07.15","price":"-0.97","value":"2.87"},{"date":"2026.07.14","price":"2.77","value":"1.54"},{"date":"2026.07.13","price":"-3.48","value":"2.88"},{"date":"2026.07.10","price":"-2.29","value":"1.37"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	陇神戎发	119.07%	19.66%	5.8分
2	珍宝岛	48.12%	14.75%	5.3分
3	上海凯宝	32.74%	8.36%	5.8分
4	-	21.91%	13.02%	分
5	汉森制药	21.17%	7.70%	6.0分
6	片仔癀	18.63%	-1.76%	5.7分
7	九芝堂	16.18%	4.75%	6.5分
8	东阿阿胶	14.13%	-2.23%	5.6分
9	新光药业	13.45%	5.12%	5.8分
10	中恒集团	13.20%	1.83%	5.2分
11	益佰制药	12.95%	5.34%	5.7分
12	天目药业	12.08%	6.06%	6.1分
13	天士力	11.65%	-2.48%	5.5分
14	-	11.58%	5.70%	分
15	佛慈制药	11.51%	4.15%	5.7分
16	以岭药业	9.54%	0.59%	5.9分
17	信邦制药	9.35%	1.67%	5.6分
18	健民集团	9.20%	6.91%	6.3分
19	亚宝药业	8.95%	5.41%	6.0分
20	昆药集团	8.89%	-2.76%	5.0分
21	葵花药业	8.43%	-1.11%	5.1分
22	济川药业	8.10%	-3.50%	5.3分
23	红日药业	7.91%	1.19%	4.9分
24	益盛药业	7.53%	1.39%	5.5分
25	古汉医药	7.33%	6.80%	5.2分
26	佐力药业	6.69%	-0.42%	5.9分
27	仁和药业	6.26%	0.00%	5.5分
28	寿仙谷	6.21%	-0.74%	5.3分
29	华润三九	5.77%	-2.63%	5.4分
30	同仁堂	5.74%	-4.86%	5.1分
31	维康药业	5.54%	22.25%	6.0分
32	太龙药业	5.53%	12.84%	6.1分
33	华神科技	5.42%	3.18%	5.8分
34	康恩贝	5.34%	0.00%	6.0分
35	恩威医药	5.29%	5.92%	5.3分
36	华润江中	5.27%	-6.14%	5.3分
37	新天药业	4.95%	4.95%	5.3分
38	振东制药	4.90%	4.26%	5.5分
39	奇正藏药	4.69%	0.00%	5.7分
40	康美药业	4.69%	-1.47%	4.1分
41	方盛制药	4.63%	2.75%	6.0分
42	精华制药	4.57%	1.93%	5.8分
43	步长制药	4.18%	2.37%	6.0分
44	ST葫芦娃	4.15%	5.05%	5.0分
45	马应龙	4.04%	-3.50%	5.6分
46	云南白药	3.97%	-3.97%	5.4分
47	千金药业	3.14%	0.72%	6.0分
48	康缘药业	2.82%	-1.01%	5.5分
49	吉林敖东	2.78%	-1.31%	5.5分
50	ST金花	2.52%	1.24%	5.6分
51	羚锐制药	2.39%	-3.30%	5.6分
52	盘龙药业	2.18%	6.28%	5.3分
53	桂林三金	1.83%	0.53%	5.8分
54	ST百灵	1.77%	-0.22%	5.6分
55	白云山	0.99%	-3.50%	5.2分
56	沃华医药	0.48%	4.13%	6.6分
57	广誉远	0.42%	-4.16%	5.4分
58	达仁堂	0.35%	-2.90%	5.4分
59	特一药业	-1.36%	6.80%	5.4分
60	太极集团	-1.81%	3.17%	5.3分
61	ST嘉应	-2.62%	1.83%	5.3分
62	众生药业	-3.25%	9.00%	6.6分
63	华森制药	-4.80%	5.80%	5.7分
64	三力制药	-6.59%	8.85%	5.8分
65	粤万年青	-11.30%	15.05%	5.5分
66	康惠股份	-11.88%	8.80%	5.9分
67	*ST香雪	-14.94%	11.75%	5.1分
68	ST万邦	-14.97%	6.52%	6.7分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.1基本面打败了59%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（75分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 14/107 ， 11/107。

[{"date":"2026-03-31","value":"4.30","vol":"2.21"},{"date":"2025-12-31","value":"16.84","vol":"-2.33"},{"date":"2025-09-30","value":"12.58","vol":"4.80"},{"date":"2025-06-30","value":"7.93","vol":"4.03"},{"date":"2025-03-31","value":"4.04","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	4.30	16.84	12.58	7.93	4.04
行业(%)	2.21	-2.33	4.80	4.03	2.24

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"75.52","vol":"55.05"},{"date":"2025-12-31","value":"73.47","vol":"52.85"},{"date":"2025-09-30","value":"73.69","vol":"53.29"},{"date":"2025-06-30","value":"73.13","vol":"53.82"},{"date":"2025-03-31","value":"73.62","vol":"54.48"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	75.52	73.47	73.69	73.13	73.62
行业(%)	55.05	52.85	53.29	53.82	54.48

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 17/107 ， 29/107。

[{"date":"2026-03-31","value":"5.52","vol":"-5.58"},{"date":"2025-12-31","value":"8.83","vol":"-6.76"},{"date":"2025-09-30","value":"4.41","vol":"-7.84"},{"date":"2025-06-30","value":"11.02","vol":"-7.78"},{"date":"2025-03-31","value":"18.24","vol":"-7.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	5.52	8.83	4.41	11.02	18.24
行业(%)	-5.58	-6.76	-7.84	-7.78	-7.40

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"7.14","vol":"1.06"},{"date":"2025-12-31","value":"11.66","vol":"-80.25"},{"date":"2025-09-30","value":"10.53","vol":"-2.78"},{"date":"2025-06-30","value":"10.74","vol":"2.25"},{"date":"2025-03-31","value":"20.25","vol":"-37.69"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	7.14	11.66	10.53	10.74	20.25
行业(%)	1.06	-80.25	-2.78	2.25	-37.69

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 30/107 ， 33/107。

[{"date":"2026-03-31","value":"0.13","vol":"0.12"},{"date":"2025-12-31","value":"0.51","vol":"0.47"},{"date":"2025-09-30","value":"0.37","vol":"0.35"},{"date":"2025-06-30","value":"0.24","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.13	0.51	0.37	0.24	0.13
行业(次)	0.12	0.47	0.35	0.24	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.50","vol":"0.59"},{"date":"2025-12-31","value":"2.02","vol":"2.34"},{"date":"2025-09-30","value":"1.43","vol":"1.72"},{"date":"2025-06-30","value":"0.89","vol":"1.17"},{"date":"2025-03-31","value":"0.48","vol":"0.59"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.50	2.02	1.43	0.89	0.48
行业(次)	0.59	2.34	1.72	1.17	0.59

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"1.59","vol":"5.83"},{"date":"2025-12-31","value":"50.64","vol":"30.77"},{"date":"2025-09-30","value":"20.07","vol":"10.53"},{"date":"2025-06-30","value":"95.30","vol":"22.82"},{"date":"2025-03-31","value":"-17.70","vol":"2.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	1.59	50.64	20.07	95.30	-17.70
行业	5.83	30.77	10.53	22.82	2.06

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.52","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.28","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.52	-	0.28	-
行业	0.00	1.00	0.00	1.03	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 53/107 ， 60/107。

[{"date":"2026-03-31","value":"4.20","vol":"2.97"},{"date":"2025-12-31","value":"3.69","vol":"2.94"},{"date":"2025-09-30","value":"3.76","vol":"3.09"},{"date":"2025-06-30","value":"4.35","vol":"2.94"},{"date":"2025-03-31","value":"4.38","vol":"3.03"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	4.20	3.69	3.76	4.35	4.38
行业	2.97	2.94	3.09	2.94	3.03

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"3.82","vol":"2.23"},{"date":"2025-12-31","value":"3.35","vol":"2.15"},{"date":"2025-09-30","value":"3.43","vol":"2.24"},{"date":"2025-06-30","value":"3.93","vol":"2.15"},{"date":"2025-03-31","value":"3.97","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	3.82	3.35	3.43	3.93	3.97
行业	2.23	2.15	2.24	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 46/107 ， 47/107。

[{"date":"2026-03-31","value":"20.02","vol":"31.94"},{"date":"2025-12-31","value":"22.55","vol":"32.43"},{"date":"2025-09-30","value":"21.77","vol":"31.59"},{"date":"2025-06-30","value":"19.17","vol":"32.45"},{"date":"2025-03-31","value":"19.17","vol":"31.91"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	20.02	22.55	21.77	19.17	19.17
行业(%)	31.94	32.43	31.59	32.45	31.91

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.25","vol":"0.66"},{"date":"2025-12-31","value":"0.29","vol":"0.67"},{"date":"2025-09-30","value":"0.28","vol":"0.76"},{"date":"2025-06-30","value":"0.24","vol":"0.75"},{"date":"2025-03-31","value":"0.24","vol":"0.74"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.25	0.29	0.28	0.24	0.24
行业(%)	0.66	0.67	0.76	0.75	0.74

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。

研究机构	评级日期	最新评级	上次评级
兴业证券	2026-07-26	增持
华泰证券	2026-05-26	增持
华创证券	2026-05-15	增持

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"7.80","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.51","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"15.57","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"17.39","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"20.02","blueLineValue":"3.11","type":"YC"}]

[东阿阿胶]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]